Boehringer Ingelheim: Prostatic Hyperplasia trials

The registry lists 18 Prostatic Hyperplasia studies with Boehringer Ingelheim as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 1Phase 4 4No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Real World Data on Management of Male LUTSCompletedNCT03075449Results posted
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.CompletedNCT02417844Phase 1Results posted
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.CompletedNCT02417831Phase 1Results posted
• Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaCompletedNCT02245555
• The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)CompletedNCT02245542
• Safety Profile of Secotex ® in Patients With Benign Prostatic HyperplasiaCompletedNCT02245529
• Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02245503
• Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary SymptomsCompletedNCT02245490Phase 4
• Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT02244346
• Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)CompletedNCT02244333
• Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)CompletedNCT02244320
• Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic BlockadeCompletedNCT02244307
• FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)CompletedNCT02244294Phase 2
• Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244268
• FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244255Phase 4
• Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT02244242Phase 4
• Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) PatientsCompletedNCT02244229Phase 4
• MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® TreatmentCompletedNCT00885027